ZNTL icon

Zentalis Pharmaceuticals

120 hedge funds and large institutions have $1.24B invested in Zentalis Pharmaceuticals in 2023 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 44 increasing their positions, 33 reducing their positions, and 36 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more ownership

Funds ownership:

less funds holding

Funds holding:

23% less capital invested

Capital invested by funds: $1.61B → $1.24B (-$371M)

25% less funds holding in top 10

Funds holding in top 10: 43 (-1)

44% less first-time investments, than exits

New positions opened: 20 | Existing positions closed: 36

Holders
120
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$17.1M
Puts
$536K
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
101
$88.4K
102
$76K
103
$54.8K
104
$51.3K
105
$37.6K
106
$15.8K
107
$13K
108
$9.97K
109
$9.86K
110
$8.56K
111
$3K
112
$1.97K
113
$1.67K
114
$1.51K
115
$1.06K
116
$455
117
$253
118
$225
119
$152
120
121
122
123
124
125